Navigation Links
New Egg Donation Program, "Ovatures," Launched By Reproductive Medicine Associates Of New Jersey
Date:9/5/2012

BASKING RIDGE, N.J., Sept. 5, 2012 /PRNewswire/ --  Reproductive Medicine Associates of New Jersey today announced the launch of its new egg donation program, Ovatures, to assist women who require donated oocytes (eggs) to become pregnant and have a family.

(Logo: http://photos.prnewswire.com/prnh/20120402/NY80340LOGO)

"At RMANJ, we understand that for some women the path to pregnancy and a positive fertility experience sometimes requires a little help.  For many, the option of egg donation can help make the dreams of family come true," said Thomas J. Kim, MD, FACOG, medical director of Ovatures. "With donor egg success rates well above the national average, RMANJ's Ovatures Egg Donation Program anonymously provides potential donors the opportunity to help another woman.  We invite women who are considering becoming egg donors to learn more about the process, and to find out if giving this priceless gift is right for them."

Women ages 21 to 31 may qualify to become anonymous egg donors following a comprehensive health assessment.  Donors are compensated for their time and effort to complete a full cycle.  Application materials, plus additional background information, are available at http://www.ovatures-eggdonation.com.

"Ovatures is unique because it is built on RMANJ's track record of successful live births, clinical excellence and innovation in fertility medicine, such as our pioneering single-embryo transfer techniques that reduce financial and health risks of multiple births," said Shefali Shastri, MD, FACOG, RMANJ.  "For many of our donors, the gift of egg donation aligns well with their support for organizations that focus on women's issues.  New donors will find comfort in RMANJ's commitment to providing world-class, patient-centered care."

Live birth rates for egg donor cycles at RMANJ were 68.8 percent in 2010 (fresh – all ages), compared to the national average of 55.6 percent, according to the Society for Assisted Reproductive Technology. Nationwide, there were more than 15,000 egg donor cycles in 2010.

M.S.'s Story
M.S. went to her regular annual gynecologist appointment, and her doctor just mentioned it ― that there are a lot of people in need, and that she was young and healthy. She said that RMANJ accepted egg donors, and that they had several locations.  It seemed to M.S. that this was a valuable thing to do, a gift she could give someone.

So I looked them up, and saw that the staff was world-class―and I wouldn't even have to take any bridges or tunnels to get there. I filled out a donor application, and spoke to them about it. There was absolutely never any pressure whatsoever, and their friendliness and expertise were outstanding. They answered every single question I had practically before I asked it, and their testing was very thorough, to make sure I was biologically and genetically suitable, checking my estrogen levels, everything. My whole actual donation time was two weeks. Most important to me, I was able to help a mom, well, get to be a mom! It is a simply amazing feeling."

- M.S., Donor

About Reproductive Medicine Associates of New Jersey
Reproductive Medicine Associates of New Jersey have pioneered and successfully implemented a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS) to more accurately detect healthy embryos that will lead to successful pregnancies and ultimately healthy babies. Other centers have attempted similar testing methods, but RMANJ is the only fertility center in the world to have developed a system of unprecedented accuracy, fully validated through years of rigorous clinical research. RMANJ's Comprehensive Chromosome Screening offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy. 

The fertility experts at RMANJ have among the highest IVF success rates in the country. Since 1999, they have helped bring more than 20,000 babies to loving families.  In addition to serving as the Division of Reproductive Endocrinology at Robert Wood Johnson University Medical School in New Brunswick, NJ, the practice has seven locations in New Jersey. For more information please call RMANJ at 973-871-1250, or visit http://www.rmanj.com.

 

 

 

 


'/>"/>
SOURCE Reproductive Medicine Associates of New Jersey
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Little known pregnancy disease, Hyperemesis Gravidarum, receives awareness with a $20,000 donation from the H.E.R. Foundation to begin Genome Research at UCLA
2. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
3. Probiotic-Enriched Instant Chai Latte and Teas to be Launched by Ganeden Biotech and Tipton Mills
4. New HydraSolve™ Lipoplasty System launched at American Society of Aesthetic Plastic Surgery Meeting
5. Foundation for Health Improvement and Technology (FHIT) Launched to Beat Cardiovascular Disease
6. Healthcare IT Accelerator Launched
7. ConnectBiotech.org Launched, a Unique Life Science Business Networking Site
8. Reproductive Medicine Associates of New Jersey and Auxogyn Launch Fertility Study To Advance Goals of One Embryo, One Healthy Baby
9. Auxogyn And Reproductive Medicine Associates of New Jersey Partner To Advance in vitro fertilization Research
10. Researchers pioneer worlds first HIV/AIDS nanomedicines
11. Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Palls Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):